Kollef M - Search Results

1

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.

Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD. Wunderink RG, et al. Among authors: kollef m. Lancet Infect Dis. 2021 Feb;21(2):213-225. doi: 10.1016/S1473-3099(20)30731-3. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058798 Clinical Trial.

2

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

Kollef MH. Kollef MH. Clin Infect Dis. 2000 Sep;31 Suppl 4:S131-8. doi: 10.1086/314079. Clin Infect Dis. 2000. PMID: 11017862 Review.

3

Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.

Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W, Fraser VJ. Kollef MH, et al. Crit Care Med. 2000 Oct;28(10):3456-64. doi: 10.1097/00003246-200010000-00014. Crit Care Med. 2000. PMID: 11057801

4

Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit.

Puzniak LA, Mayfield J, Leet T, Kollef M, Mundy LM. Puzniak LA, et al. Among authors: kollef m. Clin Infect Dis. 2001 Jul 15;33(2):151-7. doi: 10.1086/321807. Epub 2001 Jun 15. Clin Infect Dis. 2001. PMID: 11418873

5

The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient.

Shorr AF, Kollef MH. Shorr AF, et al. Chest. 2002 Jul;122(1):9-12. doi: 10.1378/chest.122.1.9. Chest. 2002. PMID: 12114331 No abstract available.

6

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH; Linezolid Nosocomial Pneumonia Study Group. Wunderink RG, et al. Clin Ther. 2003 Mar;25(3):980-92. doi: 10.1016/s0149-2918(03)80118-2. Clin Ther. 2003. PMID: 12852712 Clinical Trial.

7

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Wunderink RG, et al. Chest. 2003 Nov;124(5):1789-97. Chest. 2003. PMID: 14605050

8

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.

Shorr AF, Susla GM, Kollef MH. Shorr AF, et al. Among authors: kollef mh. Crit Care Med. 2004 Jan;32(1):137-43. doi: 10.1097/01.CCM.0000104110.74657.25. Crit Care Med. 2004. PMID: 14707572

9

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Kollef MH, Rello J, Cammarata SK, Croos-Dabrera RV, Wunderink RG. Kollef MH, et al. Intensive Care Med. 2004 Mar;30(3):388-94. doi: 10.1007/s00134-003-2088-1. Epub 2004 Jan 9. Intensive Care Med. 2004. PMID: 14714107

10

Red blood cell transfusion and ventilator-associated pneumonia: A potential link?

Shorr AF, Duh MS, Kelly KM, Kollef MH; CRIT Study Group. Shorr AF, et al. Among authors: kollef mh. Crit Care Med. 2004 Mar;32(3):666-74. doi: 10.1097/01.ccm.0000114810.30477.c3. Crit Care Med. 2004. PMID: 15090945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters